NeuroAgent: LLM Agents for Multimodal Neuroimaging Analysis and Research
Neuroimaging research often requires complex, manual workflows to turn raw brain scans into usable data. Researchers must navigate different software tools, file formats, and quality control steps, which can be time-consuming and prone to human error. NeuroAgent is an AI-driven framework designed to automate this entire process. By using a hierarchical team of "agents" powered by Large Language Models (LLMs), the system can autonomously handle the preprocessing of various brain imaging types—such as sMRI, fMRI, dMRI, and PET—and perform downstream analysis based on natural-language requests from researchers.
How the System Works
NeuroAgent functions as an intelligent orchestrator rather than a static script. It uses a "Generate-Execute-Validate" engine to manage the research pipeline. When a researcher provides a goal, a central planning agent breaks it down into specific tasks and determines the necessary steps. Specialized agents then generate the code needed to process the data using established neuroimaging tools. If a tool encounters an error, the system automatically reads the error logs, adjusts its approach, and retries the task. This loop continues until the output is validated for quality and structural integrity.
Multimodal Integration
A key strength of NeuroAgent is its ability to handle heterogeneous data. Because different types of brain scans (like structural MRI and functional MRI) often have interdependent requirements, the system automatically builds a dependency graph. For example, if a researcher requests an fMRI analysis, the system recognizes that it must first process the structural MRI to provide an anatomical reference. By integrating these disparate modalities into a single, organized dataset, the system allows for more sophisticated analyses, such as classifying Alzheimer’s disease using a combination of different scan types.
Research Performance
The researchers evaluated NeuroAgent using 1,470 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). The system demonstrated high reliability, with the most capable model achieving 84.8% correctness in end-to-end preprocessing steps. In tests for Alzheimer’s disease classification, the agent ensemble achieved an AUC of 0.9518, outperforming models that relied on only a single type of imaging data. These results suggest that the framework can significantly reduce the manual labor currently required for neuroimaging research while maintaining high scientific accuracy.
Human-in-the-Loop Oversight
While NeuroAgent is designed for autonomy, it includes a "Human-in-the-Loop" interface to ensure safety and reliability. This feature allows researchers to supervise the process, approve critical decisions, and intervene if the system encounters an edge case it cannot resolve on its own. This hybrid approach balances the efficiency of automated AI agents with the necessary oversight required for clinical and scientific research, ensuring that the system acts as a helpful assistant rather than a "black box."
Comments (0)
to join the discussion
No comments yet
Be the first to share your thoughts!